Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center

B BODAGHI, N CASSOUX, B WECHSLER… - Medicine, 2001 - journals.lww.com
There is a significant under-registration of blind and visually impaired patients attending
ophthalmic departments. Blindness is defined by the World Health Organization (WHO) as the …

Understanding uveitis: the impact of research on visual outcomes

MD de Smet, SRJ Taylor, B Bodaghi… - Progress in retinal and …, 2011 - Elsevier
The term uveitis encompasses a very diverse group of inflammatory ocular diseases that cause
a significant burden of legal and economic blindness. Indeed, the socioeconomic impact …

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells

B Bodaghi, TR Jones, D Zipeto, C Vita, L Sun… - The Journal of …, 1998 - rupress.org
Human cytomegalovirus (HCMV), a betaherpesvirus, has developed several ways to evade
the immune system, notably downregulation of cell surface expression of major …

Long-term outcome in Susac syndrome

F Aubart-Cohen, I Klein, JF Alexandra, B Bodaghi… - Medicine, 2007 - journals.lww.com
Susac syndrome is characterized by the clinical triad of encephalopathy, hearing loss, and
retinal artery branch occlusions, mostly in young women. To our knowledge, long-term …

Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study

…, J Pawade, F Willermain, B Bodaghi… - JAMA …, 2015 - jamanetwork.com
Importance The best treatment option for primary vitreoretinal lymphoma (PVRL) without
signs of central nervous system lymphoma (CNSL) involvement determined on magnetic …

Anti–tumor necrosis factor α versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network

…, S Touhami, C El Chamieh, P Cacoub, B Bodaghi… - Ophthalmology, 2022 - Elsevier
Purpose To analyze the factors associated with response (control of ocular inflammation
and corticosteroid-sparing effect) to biologics (anti–tumor necrosis factor [TNF]-α agents and …

2018 update of the EULAR recommendations for the management of Behçet's syndrome

G Hatemi, R Christensen, D Bang, B Bodaghi… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet’s syndrome (BS). The aim of the current effort was to update the …

Long‐term efficacy of the interleukin‐1 receptor antagonist anakinra in ten patients with neonatal‐onset multisystem inflammatory disease/chronic infantile neurologic …

…, A Pagnier, C Bodemer, B Bodaghi… - … : Official Journal of …, 2010 - Wiley Online Library
Objective Cryopyrin‐associated periodic syndromes (CAPS) are a group of rare autoinflammatory
diseases. Neonatal‐onset multisystem inflammatory disease (NOMID)/chronic infantile …

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease

…, M Touzot, D Seilhean, TA Tran, B Bodaghi… - Journal of Allergy and …, 2011 - Elsevier
BACKGROUND: Behçet disease (BD) is a chronic systemic inflammatory disorder of unknown
etiology. OBJECTIVE: To determine the nature of T cells driving inflammatory lesions in BD…

Ocular and central nervous system lymphoma: clinical features and diagnosis

…, H Merle-Beral, V Leblond, B Bodaghi… - Ocular immunology …, 2000 - Taylor & Francis
PURPOSE: To evaluate the clinical, angiographic, and cytopathologic features of ocular and
central nervous system (CNS) lymphoma. PATIENTS AND METHODS: Retrospective study …